TP53 and prostate carcinoma: TP53 was connected to one compound (SQ7) and 16 pathways: “cancer”, “proteoglycans in cancer,” “human cytomegalovirus infection”, “Kaposi sarcoma-associated herpesvirus infection”, “colorectal cancer”, “breast cancer”, “hepatitis C”, “endometrial cancer”, “lipid and atherosclerosis”, “bladder cancer”, “hepatitis B”, “prostate cancer”, “MAPK signaling pathway”, “thyroid hormone signaling pathway”, “human papillomavirus infection”, and “PI3K-Akt signaling pathway”.